Public policy of GST in India: A study on pharmaceutical sector with special reference to Healthcare

التفاصيل البيبلوغرافية
العنوان: Public policy of GST in India: A study on pharmaceutical sector with special reference to Healthcare
المؤلفون: Vadera M L, Gaurav Lodha, Shivani Kampani, Arun Gautam
المصدر: International Journal of Research in Pharmaceutical Sciences. 10:3136-3142
بيانات النشر: GP Innovations Pvt. Ltd., 2019.
سنة النشر: 2019
مصطلحات موضوعية: Service (business), Finance, business.industry, media_common.quotation_subject, Health care, Revenue, Public policy, General Pharmacology, Toxicology and Pharmaceutics, business, Duty, Administration (government), media_common, Tax rate
الوصف: India's greatest duty move is now a reality. 1999 was the year when GST was thought of. The amending bill for the full-powered launch of GST was approved by the Rajya Sabha on 8 August 2016, and it was enacted in late August. It is essential to comprehend that GST isn't a duty concession scheme where every good and service has become way cheaper just because the administration has decreased the duty rates. The single Revenue Neutral Rate (RNR) was a difficult system to manage, and thus the Indian govt. I wanted to fix it. Nonetheless, because of practical reasons, "four GST slabs have been set at 5%, 12%, 18%, and 28%. Precious metals have a special rate. The rate of 18% would anyway be relevant for most goods. GST was enacted on 1 July 2017."
تدمد: 0975-7538
DOI: 10.26452/ijrps.v10i4.1611
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e5e3cf5fca9ba5b20806e98b26d91b39
https://doi.org/10.26452/ijrps.v10i4.1611
Rights: OPEN
رقم الانضمام: edsair.doi...........e5e3cf5fca9ba5b20806e98b26d91b39
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09757538
DOI:10.26452/ijrps.v10i4.1611